← The Wire
GPCRNasdaq
Structure Therapeutics Inc.
Pharmaceutical Preparations · E9 · CIK 1888886
Developing novel oral small molecule therapeutics for chronic diseases by targeting G-protein coupled receptors
red 8-K · 90d
$3.05B
Market cap
$51.69
Last close
+4.0%
1D
+13.6%
5D
779K
Volume
Price · last 39 sessions+20.1%
May 4L $35.88 · H $51.69Jun 29
70
Total filings
Jun 18, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 18, 202610-Q10-QMay 7, 20268-KMaterial Agreement · Results of OperationsMay 7, 2026424B5424B5May 7, 2026DEF 14ADEF 14AApr 23, 20268-KExecutive Change · Reg FD DisclosureApr 15, 20268-KReg FD Disclosure · Company UpdateMar 16, 202610-K10-KFeb 26, 20268-KResults of OperationsFeb 26, 20268-KMaterial AgreementJan 5, 20268-KCompany UpdateDec 10, 2025424B5424B5Dec 10, 2025424B5424B5Dec 8, 20258-KReg FD Disclosure · Company UpdateDec 8, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KShareholder VoteJun 25, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 2025DEF 14ADEF 14AApr 24, 202510-K10-KFeb 27, 20258-KResults of OperationsFeb 27, 20258-KReg FD DisclosureDec 17, 202410-Q10-QNov 13, 20248-KResults of OperationsNov 13, 2024SC 13GSEC SCHEDULE 13GNov 12, 20248-KExecutive Change · Reg FD DisclosureSep 17, 20248-KExecutive ChangeAug 27, 202410-Q10-QAug 8, 20248-KResults of OperationsAug 8, 20248-KShareholder Vote · Company UpdateJun 27, 2024424B4424B4Jun 6, 20248-KCompany UpdateJun 3, 2024S-1S-1Jun 3, 20248-KReg FD Disclosure · Company UpdateJun 3, 2024SC 13GSC 13GMay 30, 202410-Q10-QMay 9, 20248-KResults of OperationsMay 9, 2024DEF 14ADEF 14AApr 25, 202410-K10-KMar 8, 20248-KResults of OperationsMar 8, 2024SC 13GSTRUCTURE THERAPEUTICS INC.Feb 14, 2024SC 13GSEC SCHEDULE 13GFeb 8, 20248-KReg FD Disclosure · Company UpdateDec 18, 2023S-1S-1Nov 17, 202310-Q10-QNov 17, 202310-Q/A10-Q/ANov 17, 202310-Q/A10-Q/ANov 16, 20238-KMaterial Agreement · Results of OperationsNov 14, 20238-KMaterial Agreement · Equity IssuanceSep 29, 20238-KReg FD DisclosureSep 29, 202310-Q10-QAug 10, 20238-KResults of OperationsAug 10, 20238-KExecutive ChangeAug 4, 20238-KMaterial AgreementJul 6, 20238-KAuditor ChangeJun 5, 202310-Q10-QMay 11, 20238-KResults of OperationsMay 11, 202310-K10-KMar 30, 20238-KResults of OperationsMar 30, 2023SC 13GTHE SCHEDULE 13GFeb 13, 2023SC 13GSC 13GFeb 10, 2023SC 13GSC 13GFeb 10, 20238-KBylaw AmendmentFeb 7, 2023424B4424B4Feb 6, 2023SC 13GSC 13GFeb 3, 2023S-1/AS-1/AJan 30, 2023S-1S-1Jan 12, 2023
Similar companies
Comparable business profile · signals at a glance